524711
VISTAPH
Start SIP
Invest Now
Start SIP in VISTAPH
Performance
- Low
- ₹9
- High
- ₹10
- 52 Week Low
- ₹8
- 52 Week High
- ₹13
- Open Price₹9
- Previous Close₹9
- Volume14,198
Investment Returns
- Over 1 Month + 1.88%
- Over 3 Month -11.21%
- Over 6 Month -10.48%
- Over 1 Year -20.49%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9
- PEG Ratio
- 0.1
- Market Cap Cr
- 60
- P/B Ratio
- 1.3
- Average True Range
- 0.69
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.06
- RSI
- 44.51
- MFI
- 20.73
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹9.74
+
0.48
(5.18%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹9.64
- 50 Day
- ₹9.82
- 100 Day
- ₹10.12
- 200 Day
- ₹10.62
Resistance and Support
9.39
- R3 10.53
- R2 10.14
- R1 9.78
- S1 9.03
- S2 8.64
- S3 8.28
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
| 2025-02-12 | Quarterly Results |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹9 As on 15 November, 2025 | 11:34
The Market Cap of Vista Pharmaceuticals is ₹60 Cr As on 15 November, 2025 | 11:34
The P/E ratio of Vista Pharmaceuticals is -9 As on 15 November, 2025 | 11:34
The PB ratio of Vista Pharmaceuticals is 1.3 As on 15 November, 2025 | 11:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.